Image

Risk Literacy Among Portuguese Medical and Dentistry Students

Risk Literacy Among Portuguese Medical and Dentistry Students

Recruiting
18-65 years
All
Phase N/A

This study is an online survey to assess risk literacy among students of the medical and dentistry faculties in Portugal.

The primary outcome is the measurement of "medical risk literacy" among Portuguese medical and dentistry students as assessed with the Quick Risk Test (QRT) and the multiple choice version of the Berlin Numeracy Test (BNT).

Secondary outcomes is to investigate whether study year, faculty, and prior statistical education have an impact on the level of risk literacy. Participants will be invited via email through established faculty mailing lists or established social media channels. For the survey, an online-survey tool (Unipark, academic program or Questback) will be used. Participation is voluntary and can be withdrawn at any time by aborting the survey (e.g. via closing the browser). Informed consent will be acquired at the beginning of the survey. English and Portuguese versions will be available to the participant.

As incentive to participate, participants completing the brief (ca.15 minutes) online-questionnaire will be granted a free subscriptions to the AMBOSS medical learning platform (2 weeks) and have the option to be entered into a lottery with the possibility of winning one of 3 free 6 month subscriptions.

After completion of the questionnaire, participants will be re-directed to a dedicated AMBOSS website where they can enter their email-address to take part in the lottery. This assures strict separation of the anonymous experimental data and the AMBOSS subscription data. Prior to initiation of the questionnaire, in the invitation email, participants will be provided the full participant information and made aware that, due to anonymity, it will not be possible to retrospectively delete their responses once the survey has been completed.

As the primary outcome is a baseline assessment and the secondary outcomes are exploratory analyses, no hypotheses will be tested in this survey.

Study details
    Medical education
    Decision Analysis

NCT04380428

Harding Center for Risk Literacy

19 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.